Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
doi: 10.18097/PBMC20226803228
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Mechanism, real evidence, FDA and WADA status
You will be notified via email or phone if there are any delays in obtaining any items on your order
For the best results: Take it for 46 weeks at a time Cycle off for 24 weeks to reset Combine it with smart nutrition, regular movement, and targeted supplements When used correctly, 5-Amino-1MQ can be a powerful cornerstone of your metabolic health strategy
US$ 29.55
US$ 20.36
US$ 28.62
US$ 29.89
US$ 24.72
US$ 27.84
